1 | | Primary | Sydney | AU | | Advanced Therapeutics Within Everyone's Reach | N/A | Anthony Priyashantha Boteju | Head Of Marketing at Celltrion Healthcare Australia Pty Ltd |
2 | | Primary Wagramer Straße 19 | Vienna | AT | | Advancing Therapeutics. Improving Lives | N/A | Catia Lourenco | Receptionist |
3 | | Primary St. Alban-Anlage 44 | Basel | CH | | Selective Mode Antimicrobial Resistance Therapeutics | N/A | Frank Otto Gombert | CEO bei Selmod |
4 | | Primary Leonhardstraße 109 | Graz | AT | | Brain Implant Therapeutics | N/A | N/A | N/A |
5 | | Primary 26 Robinglade Dr | Toronto | CA | | The Therapeutics & Nutrition Cooperation | N/A | N/A | N/A |
6 | | Primary 19 Morris Ave. Building 128 | Brooklyn | US | | People-Driven Therapeutics | N/A | Stephane Castel | Co-Founder at Variant Bio |
7 | | Primary Mesogeiwn 2- 4 Athens Tower | Athens | GR | | Health & Fertility Therapeutics | N/A | Harroula Mathiopoulou Bilali | Molecular Biologist| Health Futurist| Genomics, Biotech, Pharma |
8 | | Primary London Bioscience Innovation Centre, 2 Royal College Street | LONDON | GB | | Innovative Ocular and Cancer Therapeutics | N/A | Salman Rahman | Commercial Lead at University of Hertfordshire--------President and Co-founder of VASGEN LIMITED |
9 | | Primary 3401 Market St | Philadelphia | US | | Discovering Novel Antiviral Therapeutics | N/A | Michael Saporito | Biopharmaceutical Consultant |
10 | | Primary London | London | GB | | Digital Therapeutics For Digestive Health | N/A | elena mustatea | Chief Executive Officer |
11 | | Primary 35 CambridgePark Dr | Cambridge | US | | Leaders In Exosome Therapeutics | N/A | Aaron Noyes | Director at Codiak BioSciences |
12 | | Primary Mesogeiwn 2- 4 Athens Tower | Athens | GR | | Health & Fertility Therapeutics | N/A | Harroula Mathiopoulou Bilali | Molecular Biologist| Health Futurist| Genomics, Biotech, Pharma |
13 | | Primary | Cambridge | US | | Redefining Cancer Therapeutics | N/A | scott robinson | president and chief strategy officer |
14 | | Primary | Zurich | CH | | Antibacterial Therapeutics | N/A | Gunter Festel | Entrepreneur / Festel Capital / Founding Angel / Professor TU Berlin |
15 | | RENEURON PENCOED BUSINESS PARK | PENCOED | GB | | Pioneering Stem Cell Therapeutics | N/A | Nicholas Adams | VP Business Development & Alliance Management at RENEURON GROUP PLC |
16 | | RENEURON PENCOED BUSINESS PARK | PENCOED | GB | | Pioneering Stem Cell Therapeutics | N/A | olav hellebo | Chief Executive Officer |
17 | | Primary Gorbachev Street 002 E, VIT incubation cell, Vellore Institute of Technology | Vellore | IN | | Redefining Diagnostics and Therapeutics | N/A | Ravi Kiran Manapuram, PhD | Principal Investigator and Director at MedevPlus |
18 | | Primary Avenida Tenente Valadim 17, 2F | Torres Vedras | PT | | Targeted Therapeutics | N/A | Raúl G. Saraiva, PhD | Biomedical Investment Manager at Portugal Ventures |
19 | | Primary Via Borgogna, 5 | Milan | IT | | First-In-Class Therapeutics For Autoimmune Disorders | N/A | Aurelia Ramunni | Executive Assistant at Enthera Pharmaceuticals |
20 | | Primary Hans-Bunte-Str. 19 | Freiburg | DE | | Unlocking Novel Therapeutics | N/A | andreas schaaf | managing director and chief strategy officer |